Biomarin Pharmaceutical (NASDAQ:BMRN) reported quarterly sales of $537.54 million which beat the analyst consensus estimate of $536.97 million by 0.11 percent. This is a 19.50 percent increase over sales of $449.81 million the same period last year.
Cathie Wood Buys Whopping $21M Worth Of Shares In This Social Commerce Company Even As ARK Continues To Dump Coinbase, GBTC
Cathie Wood’s Ark Invest picked up huge chunk of shares in social commerce company Pinterest, Inc. (NYSE:PINS) and dumped more of crypto-linked stocks on Friday, daily trade disclosure from the firm showed.
